首页> 美国卫生研究院文献>Asian Journal of Andrology >Population-standardized genetic risk score: the SNP-based method ofchoice for inherited risk assessment of prostate cancer
【2h】

Population-standardized genetic risk score: the SNP-based method ofchoice for inherited risk assessment of prostate cancer

机译:人群标准化遗传风险评分:基于SNP的方法前列腺癌遗传风险评估的最佳选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several different approaches are available to clinicians for determining prostate cancer (PCa) risk. The clinical validity of various PCa risk assessment methods utilizing single nucleotide polymorphisms (SNPs) has been established; however, these SNP-based methods have not been compared. The objective of this study was to compare the three most commonly used SNP-based methods for PCa risk assessment. Participants were men (n = 1654) enrolled in a prospective study of PCa development. Genotypes of 59 PCa risk-associated SNPs were available in this cohort. Three methods of calculating SNP-based genetic risk scores (GRSs) were used for the evaluation of individual disease risk such as risk allele count (GRS-RAC), weighted risk allele count (GRS-wRAC), and population-standardized genetic risk score (GRS-PS). Mean GRSs were calculated, and performances were compared using area under the receiver operating characteristic curve (AUC) and positive predictive value (PPV). All SNP-based methods were found to be independently associated with PCa (all P < 0.05; hence their clinical validity). The mean GRSs in men with or without PCa using GRS-RAC were 55.15 and 53.46, respectively, using GRS-wRAC were 7.42 and 6.97, respectively, and using GRS-PS were 1.12 and 0.84, respectively (all P < 0.05 for differences between patientswith or without PCa). All three SNP-based methods performed similarly indiscriminating PCa from non-PCa based on AUC and in predicting PCa risk based on PPV(all P > 0.05 for comparisons between the three methods), andall three SNP-based methods had a significantly higher AUC than family history (allP < 0.05). Results from this study suggest that while thethree most commonly used SNP-based methods performed similarly in discriminating PCafrom non-PCa at the population level, GRS-PS is the method of choice for riskassessment at the individual level because its value (where 1.0 represents averagepopulation risk) can be easily interpreted regardless of the number ofrisk-associated SNPs used in the calculation.
机译:临床医生可以使用几种不同的方法来确定前列腺癌(PCa)的风险。已经建立了利用单核苷酸多态性(SNP)的各种PCa风险评估方法的临床有效性;但是,这些基于SNP的方法尚未进行比较。这项研究的目的是比较三种最常用的基于SNP的PCa风险评估方法。参加研究的前瞻性研究对象为男性(n = 1654)。该队列中有59种与PCa风险相关的SNP的基因型。使用三种计算基于SNP的遗传风险评分(GRS)的方法来评估个体疾病风险,例如风险等位基因计数(GRS-RAC),加权风险等位基因计数(GRS-wRAC)和人群标准化遗传风险评分(GRS-PS)。计算平均GRS,并使用接收器工作特征曲线(AUC)和阳性预测值(PPV)下的面积比较性能。发现所有基于SNP的方法均与PCa独立相关(所有P <0.05;因此其临床有效性)。使用GRS-RAC的有或没有PCa的男性的平均GRS分别为55.15和53.46,使用GRS-wRAC的男性分别为7.42和6.97,使用GRS-PS的分别为1.12和0.84(两者之间的差异均为P <0.05耐心有或没有PCa)。三种基于SNP的方法在基于AUC区分PCa与非PCa,以及基于PPV预测PCa风险(对于三种方法之间的比较,所有P> 0.05),以及三种基于SNP的方法的AUC均显着高于家族史(所有P <0.05)。这项研究的结果表明,三种最常用的基于SNP的方法在区分PCa中执行相似的操作从非PCa人群的角度来看,GRS-PS是选择风险的方法在个人层面进行评估,因为其价值(其中1.0代表平均值人口风险),无论计算中使用的与风险相关的SNP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号